Cerebrosthenic syndrome is a non-specific neurological syndrome, which is characterized by a decrease in working capacity, impaired attention and memory, increased fatigue, as well as headaches, severe exhaustion of the nervous system and various vegetative manifestations. In addition, there is an increase in the duration of sleep and a decrease in wakefulness, emotional lability of the patient and motor anxiety. Cerebrosthenic syndrome in children is often accompanied by increased congenital reflexes, spontaneous Moro reflex and autonomic disorders.
The main causes of cerebrostenic syndrome are the pathological course of pregnancy and subsequent childbirth, which caused a violation of the supply of oxygen to the baby’s brain. Other pathological conditions that provoke the development of this syndrome include taking medications during pregnancy, intrauterine infections, prematurity, intracranial hemorrhages, sepsis, hemolytic disease, pneumonia.
Until recently, newborns diagnosed with cerebrosthenic syndrome did not survive, but at present, due to the development of qualified neonatological care, perinatal mortality rates have decreased significantly. And as a result, the number of children with certain learning difficulties and developmental disorders has increased, as a long-term result of the pathology of the neonatal period, childbirth and pregnancy. For the same reason, cerebrosthenic syndrome occurs in adults.
Quite often, cerebrosthenic syndrome develops in school and preschool children who have suffered concussion or brain injury, meningitis, encephalitis, as well as general infections with toxic damage to brain tissue. In addition, this disease can develop in most children who have had to undergo surgery, and anemic, circulatory and histotoxic hypoxia are the impetus for its development.
The main clinical manifestations of cerebrosthenic syndrome:
- "irritable weakness";
- lethargy, general passivity, slowness of movements and thinking;
- increased fatigue and exhaustion, even with minor mental stress;
- low mood background;
- headaches amid overwork;
- dizziness and nausea;
- poor tolerance of heat and stuffiness, sudden changes in atmospheric pressure.
These manifestations are characterized by an increase after vaccination, stressful situations, under the influence of intercurrent diseases and trauma. It is believed that irritability, increased irritability, affective explosiveness, as well as hyperesthesia to bright light and sounds, are most characteristic for post-traumatic cerebral growth, and moodiness, mood swings, tearfulness, and a feeling of discontent are the most common for post-infectious cerebration.
As practice shows, the treatment of such a disorder as cerebrosthenic syndrome should begin immediately after the first clinical manifestations of the disease. Treatment depends on how severely expressed violations of certain functions, it should be primarily aimed at stimulating and restoring the normal functioning of central regulatory mechanisms. A single generally accepted treatment for this disorder does not yet exist. As a rule, therapeutic measures are symptomatic and are based on the experience and intuition of the doctor. So, if the patient has a convulsive syndrome , drugs such as diphenyl, phenobarbital, depakine and finlepsin are prescribed. To stimulate metabolic processes in the brain tissues, amino acids, nootropic drugs and adaptogens are indicated. In the treatment of hypertension syndrome , diacarb is used, in the presence of muscle hypotension - proserin, and in the case of muscle hypertension syndrome - dibazole and midocal. Cerebral circulation is improved with antispasmodics: dibazole, aminophylline, pentoxifylline and cinnarizine.